| Item Type | Name |
|
Academic Article
|
A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium.
|
|
Academic Article
|
Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.
|
|
Academic Article
|
Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma.
|
|
Academic Article
|
Development of a composite vascular scaffolding system that withstands physiological vascular conditions.
|
|
Academic Article
|
Regenerative medicine and organ transplantation: past, present, and future.
|
|
Academic Article
|
Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors.
|
|
Concept
|
Astemizole
|
|
Concept
|
MyoD Protein
|
|
Concept
|
Laminin
|
|
Concept
|
Integrin alpha6
|
|
Concept
|
Homeodomain Proteins
|
|
Concept
|
Drug Screening Assays, Antitumor
|
|
Concept
|
Hepatocyte Growth Factor
|
|
Concept
|
Muscle Development
|
|
Concept
|
Polyesters
|
|
Concept
|
Thrombospondins
|
|
Concept
|
Proto-Oncogene Proteins c-myc
|
|
Concept
|
Vascular Endothelial Growth Factor C
|
|
Concept
|
Albumins
|
|
Concept
|
Glycolates
|
|
Concept
|
Developmental Biology
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Gelatin
|
|
Concept
|
Alkaline Phosphatase
|
|
Concept
|
Detergents
|
|
Concept
|
Green Fluorescent Proteins
|
|
Concept
|
Transforming Growth Factor alpha
|
|
Concept
|
Recombinant Fusion Proteins
|
|
Concept
|
Gold
|
|
Concept
|
Myogenic Regulatory Factor 5
|
|
Concept
|
Cross-Linking Reagents
|
|
Concept
|
Tubulin
|
|
Concept
|
Aspartate Aminotransferases
|
|
Concept
|
Fibronectins
|
|
Concept
|
Receptors, Mitogen
|
|
Concept
|
Potassium
|
|
Concept
|
Collagen Type I
|
|
Concept
|
Crystallization
|
|
Concept
|
Myosin Heavy Chains
|
|
Concept
|
Glial Fibrillary Acidic Protein
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
C-Peptide
|
|
Concept
|
Heparin
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
Trans-Activators
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Collagen Type II
|
|
Concept
|
Transforming Growth Factors
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Fibrin
|
|
Concept
|
Cytochrome P-450 Enzyme System
|
|
Concept
|
Culture Media
|
|
Concept
|
Calcium
|
|
Concept
|
Nuclear Proteins
|
|
Concept
|
Recombinant Proteins
|
|
Concept
|
Central Nervous System Depressants
|
|
Concept
|
Mitomycin
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
|
Concept
|
Urea
|
|
Concept
|
Gluconates
|
|
Concept
|
Acetylcysteine
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Fluorouracil
|
|
Concept
|
Extracellular Matrix Proteins
|
|
Concept
|
Lymphokines
|
|
Concept
|
Receptors, Growth Factor
|
|
Concept
|
Culture Media, Serum-Free
|
|
Concept
|
DNA Primers
|
|
Concept
|
Vascular Endothelial Growth Factors
|
|
Concept
|
Drug Evaluation, Preclinical
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Gene Expression Regulation, Developmental
|
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
|
Concept
|
Maf Transcription Factors, Large
|
|
Concept
|
Growth Substances
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Bone Morphogenetic Proteins
|
|
Concept
|
Biocompatible Materials
|
|
Concept
|
Alanine Transaminase
|
|
Concept
|
Tyrosine
|
|
Concept
|
RNA, Neoplasm
|
|
Concept
|
Vasoconstrictor Agents
|
|
Concept
|
Coated Materials, Biocompatible
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Neuropilin-1
|
|
Concept
|
Polyglycolic Acid
|
|
Concept
|
Ferric Compounds
|
|
Concept
|
Activins
|
|
Concept
|
P-Selectin
|
|
Concept
|
Free Radical Scavengers
|
|
Concept
|
Nitric Oxide Synthase Type III
|
|
Concept
|
Endostatins
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Cytokines
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Insulin
|
|
Concept
|
Basic Helix-Loop-Helix Transcription Factors
|
|
Concept
|
Apoptosis
|
|
Concept
|
Pharmaceutical Preparations
|
|
Concept
|
Elastin
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Antigens
|
|
Concept
|
Ouabain
|
|
Concept
|
von Willebrand Factor
|
|
Concept
|
Nicotine
|
|
Concept
|
Niacinamide
|
|
Concept
|
Hydrogels
|
|
Concept
|
Osteopontin
|
|
Concept
|
Bone Morphogenetic Protein 7
|
|
Concept
|
Drug Discovery
|
|
Concept
|
Lactic Acid
|
|
Concept
|
Quinazolines
|
|
Concept
|
Collagenases
|
|
Concept
|
Antigens, Differentiation
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-1
|
|
Concept
|
Actins
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Angiogenesis Inducing Agents
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Glycosaminoglycans
|
|
Concept
|
Fluorescent Dyes
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Cadherins
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Injections
|
|
Concept
|
Silicon Dioxide
|
|
Concept
|
Neuropilins
|
|
Concept
|
Peptides
|
|
Concept
|
Endothelial Growth Factors
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Pesticides
|
|
Concept
|
Epidermal Growth Factor
|
|
Concept
|
Desmin
|
|
Concept
|
Macromolecular Substances
|
|
Concept
|
Stage-Specific Embryonic Antigens
|
|
Concept
|
Angiogenesis Modulating Agents
|
|
Concept
|
Chondroitin Sulfates
|
|
Concept
|
Wnt Proteins
|
|
Concept
|
Transforming Growth Factor beta3
|
|
Concept
|
Hyaluronic Acid
|
|
Concept
|
Collagen Type IV
|
|
Concept
|
Proteome
|
|
Concept
|
Collagen
|
|
Concept
|
Ethanol
|
|
Concept
|
Solutions
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Quartz
|
|
Concept
|
Integrins
|
|
Concept
|
Tyrosine 3-Monooxygenase
|
|
Concept
|
Neuropilin-2
|
|
Concept
|
Intramolecular Oxidoreductases
|
|
Concept
|
Affinity Labels
|
|
Concept
|
Skin, Artificial
|
|
Concept
|
Protein Isoforms
|
|
Concept
|
Piperidines
|
|
Concept
|
Culture Media, Conditioned
|
|
Concept
|
Genetic Vectors
|
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
|
Concept
|
Bone Morphogenetic Protein 2
|
|
Concept
|
Azacitidine
|
|
Concept
|
Base Sequence
|
|
Concept
|
Platelet Activating Factor
|
|
Concept
|
Fibroblast Growth Factor 2
|
|
Concept
|
Nerve Tissue Proteins
|
|
Concept
|
Hydrochloric Acid
|
|
Concept
|
PAX7 Transcription Factor
|
|
Academic Article
|
Tissue-engineered autologous vaginal organs in patients: a pilot cohort study.
|
|
Academic Article
|
Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro.
|
|
Academic Article
|
The combined effect of PDX1, epidermal growth factor and poly-L-ornithine on human amnion epithelial cells' differentiation.
|
|
Academic Article
|
A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening.
|
|
Academic Article
|
Sustained Depolarization of the Resting Membrane Potential Regulates Muscle Progenitor Cell Growth and Maintains Stem Cell Properties In Vitro.
|
|
Grant
|
Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine
|
|
Grant
|
Cord Blood Expansion Inside a Bioengineered Liver
|
|
Grant
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
|
Grant
|
Optical Molecular Tomography for Regenerative Medicine
|
|
Grant
|
Nondestructive, High Resolution Imaging Platform For Tissue Regeneration Research
|
|
Grant
|
ASC101 Enhancement of Regenerative Capacity of Amniotic Fluid-derived Stem Cells
|
|
Academic Article
|
Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy.
|
|
Academic Article
|
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.
|
|
Academic Article
|
Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer.
|
|
Academic Article
|
Optical Tracking and Digital Quantification of Beating Behavior in Bioengineered Human Cardiac Organoids.
|
|
Academic Article
|
Shear stress upregulates regeneration-related immediate early genes in liver progenitors in 3D ECM-like microenvironments.
|
|
Grant
|
Students and Young Investigators Activities at the 2017 TERMIS-Americas Meeting
|
|
Academic Article
|
A real-time monitoring platform of myogenesis regulators using double fluorescent labeling.
|
|
Academic Article
|
Naturally-Derived Biomaterials for Tissue Engineering Applications.
|
|
Academic Article
|
Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening.
|
|
Academic Article
|
Drug compound screening in single and integrated multi-organoid body-on-a-chip systems.
|
|
Academic Article
|
3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications.
|